United States· US:23155-771_7de2fbfd-a1c3-4320-8212-bfeeff0a20a4

foscarnet sodium

A foscarnet product containing foscarnet sodium, registered in United States by Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.. The same ATC class is registered in 12 of our 19 countries.

ATC J05AD01US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedfoscarnet sodiumATCJ05AD01REGISTER NO.US:23155-771_7de2fbfd…PACKS LISTED2CHECKEDSeptember 27, 2026

Where it is registered

Foscarnet is registered in 12 of 19 countries.

Countries holding a registration under ATC J05AD01 (foscarnet), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 7 of them publish a price we can compare per daily dose

Foscarnet · ATC J05AD01

12 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
FOSCARNET SODIUM
Manufacturer
Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
Country
United States (US)
ATC code
J05AD01
ATC class
Foscarnet
Defined daily dose
6.5 g, P
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    2315577131
    1 BOTTLE, GLASS in 1 CARTON (23155-771-31) / 250 mL in 1 BOTTLE, GLASS
  • ndc11
    23155-771-31

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

245 interactions on record for foscarnet.

Graded by severity as the source publishes them — 70 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Foscarnet · interactions on record

245 records

  • 70 severe
  • 157 moderate
  • 2 minor
  • 16 info

Most severe, free to view

  • PapaverineA03AD01severe
  • CisaprideA03FA02severe
  • DolasetronA04AA04severe
  • NeomycinA07AA01severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Foscarnet in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All foscarnet products

Authorised across Europe · EMA

The same active substance is authorised in 24 EEA countries. Names it is sold under:

  • Austria · Foscarnet Tillomed
  • Belgium · Foscarnet Fresenius Kabi, Foscavir
  • Czechia · Foscarnet Tillomed
  • Germany · Foscarnet Kabi, Foscarnet Tillomed
  • Denmark · Foscarnet Tillomed, Virafosc
  • Estonia · Foscarnet Sodium Tillomed
  • Spain · Foscarnet Kabi, Foscarnet Tillomed
  • Finland · Foscarnet Tillomed, Virafosc
  • France · Foscarnet Kabi, Foscarnet Medipha
  • United Kingdom (Northern Ireland) · Foscarnet Sodium Fresenius Kabi Ltd, Foscarnet Sodium Tillomed
  • Greece · Foscarnet Tillomed
  • Hungary · Foscavir
  • Ireland · Foscarnet Sodium Hexahydrate Tillomed
  • Italy · Foscarnet Kabi, Foscarnet Tillomed
  • Lithuania · Foscarnet Sodium Hexahydrate Tillomed
  • Luxembourg · Foscavir
  • Latvia · Foscarnet Sodium Tillomed
  • Malta · Foscarnet Kabi
  • Netherlands · Foscarnet Tillomed, Foscavir
  • Norway · Foskarnetnatriumheksahydrat Tillomed, Virafosc
  • Poland · Foscarnet Tillomed
  • Portugal · Foscarneto Sódico Kabi, Foscarneto Sódico Tillomed
  • Sweden · Foscarnet Tillomed, Virafosc
  • Slovakia · Foscarnet Tillomed

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/9d7b7d94-b5cb-4b15-bd03-a25deaa33a42
GET /v1/drugs/9d7b7d94-b5cb-4b15-bd03-a25deaa33a42?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "INTRAVENOUS",
  "source": "ndc",
  "strength": "24",
  "substance": "FOSCARNET SODIUM",
  "productndc": "23155-771",
  "dosage_form": "INJECTION, SOLUTION",
  "dea_schedule": null,
  "strength_unit": "mg/mL",
  "application_number": "ANDA213807",
  "marketing_category": "ANDA"
}

See everything about foscarnet.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.